Anti-Idiotype Tumor Vaccines

  • Malaya Bhattacharya-Chatterjee
  • Heinz Kohler


The immunotherapy of human cancer using tumor cells or tumor-derived vaccines has been disappointing for several reasons. It has been consistently difficult to obtain large quantities of pure tumor antigens which are often chemically ill-defined and difficult to purify. In addition, there is the question whether there exists truly tumor-specific antigens and finally, there remains the problem of the immunobiological response potential against tumor antigens, or in other words, the question whether a cancer patient can mount effectively an immune response against his tumor. Tumor-associated antigens are often a part of “self” and usually evoke a very poor immune response in a tumor-bearing host due to a state of T cell-mediated suppression (Haubeck and Kolsch, 1982; Howie and McBride, 1982) and also because of tolerance to the antigen (Greene, 1980; McBride and Howie, 1986). Immunobiologists have learned that a poor antigen can be turned into a strong antigen by simply changing the molecular environment of the haptenic structure. Such changes of the carrier for haptens allow T cell help to become active, making the overall immune response stronger.


Tumor Antigen Internal Image Gp37 Antigen Idiotypic Determinant Idiotype Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bhattacharya, M., Chatterjee, S. K., Barlow, J. J., and Fuji, H., 1982, Monoclonal antibodies recoginzing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas, Cancer Res., 42:1650.PubMedGoogle Scholar
  2. Bhattacharya-Chatterjee, M., Pride, M. W., Seon, B. K., and Kohler, H., 1987, Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes. J. Immunol., 139:1354PubMedGoogle Scholar
  3. Bhattacharya-Chatterjee, M., Chatterjee, S. K., Vasile, S., Seon, B. K., and Kohler, H., 1988, Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2 and Ab3), J. Immunol., 141:1398.PubMedGoogle Scholar
  4. Bona, C. A., and Kohler, H., 1984, Anti-idiotypic antibodies and internal images, in: “Probes for Receptor Structure and Function”, J. C. Venter, C. M. Fraser, and J. Lindstrom, eds., Alan R. Liss, Inc., New York, pp. 141–150.Google Scholar
  5. Bowman, W. P., Melvin, S. L., Aur, R. J. A., and Mauer, A. M., 1981, A clinical perspective on cell markers in acute lymphocytic leukemia, Cancer Res., 41:4794.PubMedGoogle Scholar
  6. Campbell, M. J., Carroll, W., Kon, S., Thielemans, K., Rothbard, J. B., Levy, S., and Levy, R., 1988, Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived IgM and its molecular subunits, J. Immunol., in press.Google Scholar
  7. Campbell, M. J., Esserman, L., and Levy, R., 1988, Immunotherapy of established murine B cell lymphoma. Combination of idiotype vaccine and cyclophosphamide, J. Immunol., 141:3227.PubMedGoogle Scholar
  8. Carrel, S., Schmidt-Kessen, A., and Giuffre, L., 1985, Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens, Eur. J. Immunol., 15:118.PubMedCrossRefGoogle Scholar
  9. Gangopadhyay, A., Bhattacharya, M., Chatterjee, S. K., Barlow, J. J., and Tsukada, Y., 1985, Immunoperoxidase localization of a high molecular weight mucin recognized by monoclonal antibody 103, Cancer Res., 45:1650.Google Scholar
  10. Greaves, M. F., 1981, Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia, Cancer Res., 41:4752.PubMedGoogle Scholar
  11. Greene, M. I., 1980, Cellular and genetic basis of immune reactivity to tumor cells, Contemp. Top. Mol. Immunol., 11:81.CrossRefGoogle Scholar
  12. Hara, H., and Seon, B. K., 1987, Complete suppression of in vivo growth of human leukemia cells by specific immunotoxins: Nude mouse models, Proc. Natl. Acad. Sci. USA, 84:3390.PubMedCrossRefGoogle Scholar
  13. Haubeck, H. D., and Kolsch, E., 1982, Tumor-specific T suppressor cells induced at early stage of tumorigenesis act on the induction phase of cytotoxic T cells, Immunology, 47:503.PubMedGoogle Scholar
  14. Herlyn, D., Ross, A. H., and Koprowski, H., 1986, Anti-idiotypic antibodies bear the interal image of a human tumor antigen, Science, 232:100.PubMedCrossRefGoogle Scholar
  15. Herlyn, D., Wettendorff, M., Schmoll, E., Iliopoulos, D., Schedel, I., Drejkhausen, U., Raab, R., Ross, A. H., and Koprowski, H., 1987, Anti-idiotype immunization of cancer patients: Modulation of the immune response, Proc. Natl. Acad. Sci. USA, 84:8055.PubMedCrossRefGoogle Scholar
  16. Howie, S. M., and McBride, W. H., 1982, Tumor specific T helper activity can be abrogated by two distinct suppressor cell mechanisms, Eur. J. Immunol., 12:671.PubMedCrossRefGoogle Scholar
  17. Jerne, N. K., 1974, Towards a network theory of the immune system, Ann. Immunol., (Paris) , 124C:171.Google Scholar
  18. Jerne, N. K., 1984, Idiotypic networks and other preconceived ideas, Immunol. Rev., 79:5.PubMedCrossRefGoogle Scholar
  19. Jerne, N. K., Roland, J., and Cazenave, P. A., 1982, Recurrent idiotypes and internal images, EMBO J., 1:243.PubMedGoogle Scholar
  20. Kaminski, M. S., Kitamura, K., Maloney, D. G., and Levy, R., 1987, Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein, J. Immunol., 138:1289.PubMedGoogle Scholar
  21. Kennedy, R. C., Dreesman, G. R., and Kohler, H., 1985, Vaccines utilizing internal image anti-idiotypic antibodies that mimic antigens of infectious organism, Biotechniques, 3:404.Google Scholar
  22. Kennedy, R. C., Dreesman, G. R., Butel, J. S., and Lanford, R. E., 1985, Suppression of in vivo tumor formation induced by simian virus 40 transformed cells in mice receiving anti-idiotypic antibodies, J. Exp. Med., 161:1432.PubMedCrossRefGoogle Scholar
  23. Kieber-Emmons, T., Ward, R. E., Raychaudhuri, S., Rein, R., and Kohler, H., 1986, Rational design and application of idiotope vaccines, Intern. Rev. Immun., 1:1.CrossRefGoogle Scholar
  24. Kohler, H., 1985, The immune network revisited, in: “Idiotypes in Biology and Medicine”, H. Kohler, J. Urbaiin, and P. Cazenave, eds., Academic Press, New York, pp. 3–28.Google Scholar
  25. Kohler, H., Muller, S., and Bona, C., 1985, Internal antigen and the immune network, Proc. Soc. Exp. Biol. Med., 178:189.PubMedGoogle Scholar
  26. Kusama, M., Kageshita, T., Kim, K. T., and Ferrone, S., 1987, Antiidiotypic monoclonal antibodies to antihuman high molecular weight melanoma-associated antigen monoclonal antibodies, Proc. Am. Assoc. Cancer Res., 28:361.Google Scholar
  27. Liao, S. K., Kwong, P. C., Khosravi, M., and Dent, P. B., 1982, Enhanced expression of melanoma-associated antigens and — microglobulin on cultured melanoma cells by intetferon, J. Natl. Cancer Inst. 68:19PubMedGoogle Scholar
  28. Lindemann, J., 1973, Speculation of idiotypes and homobodies, Ann. Immunol., 124C:171.Google Scholar
  29. McBride, W. H., and Howie, S. M., 1986, Induction of tolerance to a murine fibrosarcoma in two zones of dosage-the involvement of suppressor cells, Br. J. Cancer, 53:707.PubMedCrossRefGoogle Scholar
  30. McNamara, M. K., Ward, R. E., and Kohler, H., 1984, Monoclonal idiotype vaccine against Streptococcus pneumoniae infection, Science, 226:1325.PubMedCrossRefGoogle Scholar
  31. Nelson, K. A., George, E., Swenson, C., Forstrom, J. W., and Hellstrom, K. E., 1987, Immunotherapy of murine sarcomas and auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells, J. Immunol. , 139:2110.PubMedGoogle Scholar
  32. Nepom, G. T., Nelson, K. A., Holbeck, S. L., Hellstrom, I., and Hellstrom, K. E., 1984, Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice, Proc. Natl. Acad. Sci. USA, 81:2864.PubMedCrossRefGoogle Scholar
  33. Nisonoff, A., and Lamoyi, E., 1981, Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production, Clin. Immunol. Immunopathol., 21:397.PubMedCrossRefGoogle Scholar
  34. Oldham, R. K., Morgan, A. C., Woodhouse, C., Schroff, R. W., Abrams, P., and Foon, K., 1984, Monoclonal antibodies in the treatment of cancer: preliminary observations and future prospects, Med. Oncol. and Tumor Pharmacother., 1:51.Google Scholar
  35. Raychaudhuri, S., Saeki, Y., Fuji, H., and Kohler, H., 1986, Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen, J. Immunol., 137:1743.PubMedGoogle Scholar
  36. Raychaudhuri, S., Saeki, Y., Chen, J. J., Iribe, H., Fuji, H., and Kohler, H., 1987, Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2), J. Immunol., 139:271.PubMedGoogle Scholar
  37. Raychaudhuri, S., Saeki, Y., Chen, J. J., and Kohler, H., 1987, Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells, J. Immunol., 139:2096.PubMedGoogle Scholar
  38. Sallan, S. E., Ritz, J., Pesando, J., Gelber, R., O’Brien, C., Hitoncock, S., Coral, F., and Schlossman, S. F., 1980, Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia, Blood, 55:395.PubMedGoogle Scholar
  39. Schroff, R. W., Foon, K. A., Wilburn, S. B., Oldham, R. K., and Morgan, A. C., 1985, Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy, Cancer Res., 45:879.PubMedGoogle Scholar
  40. Seon, B. K. , 1984, Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies, Cancer Res., 44:259.PubMedGoogle Scholar
  41. Seon, B. K., Negoro, S., and Barcos, M., 1983, Monoclonal antibody that defines a unique human T-cell leukemia antigen, Proc. Natl. Acad. Sci. USA, 80:845.PubMedCrossRefGoogle Scholar
  42. Seon, B. K., Negoro, S., Barcos, M. P., Tebbi, C. K., Chervinsky, D., and Fukukawa, T., 1984, Monoclonal antibody SN2 defining a human T cell leukemia associated cell surface glycoprotein, J. Immunol., 132:2089.PubMedGoogle Scholar
  43. Seon, B. K., Fukukawa, T., Jackson, A. L., Chervinsky, D., Tebbi, C. K., Freeman, A. L., and Matsuzaki, H., 1986, Human T-cell leukemia-associated cell surface glycoprotein GP37: studies with three monoclonal antibodies and a rabbit antiserum, Mol. Immunol., 23:569.PubMedCrossRefGoogle Scholar
  44. Stevenson, F. K., and Gordon, J., 1983, Immunization of idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation, J. Immunol., 130: 970.PubMedGoogle Scholar
  45. Sugai, S., Palmer, D. W., Talal, N., and Witz, L. Y., 1974, Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB/NZWF mice, J. Exp. Med., 140:1547.PubMedCrossRefGoogle Scholar
  46. Tebbi, C. K., Chervinsky, D., and Seon, B. K., 1985, Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells, Clin. Exp. Immunol., 60:496.PubMedGoogle Scholar
  47. UydeHaag, F. G. C. H., Bunschoten, H., Weijer, K., and Osterhaus, A. D. M. E., 1986, From Jenner to Jerne: Towards idiotype vaccines, Immunol. Rev., 90:93.CrossRefGoogle Scholar
  48. Viale, G., Grassi, F., Pelagi, M., Alzani, R., Menara, Miotti, S., Buffa, R., Gini, A., and Siccardi, A. G., 1987, Anti-human tumor antibodies induced in mice and rabbits by “internal image” anti-idiotypic monoclonal immunoqlobulins, J. Immunol., 139:4250.PubMedGoogle Scholar
  49. Ziai, M. R., Armandola, E., Hyashibe, K., Giordano, A., Kageshita, T., Mittelman, A., and Ferrone, S., 1988, Triggering of the idiotype network in a patient with melanoma injected with murine anti-idiotypic monoclonal antibodies, Proc. Am. Assoc. Cancer Res., 29:436.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Malaya Bhattacharya-Chatterjee
    • 1
  • Heinz Kohler
    • 2
  1. 1.Roswell Park Memorial InstituteBuffaloUSA
  2. 2.Dept. of PathologyUniversity of California at San DiegoSan DiegoUSA

Personalised recommendations